Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04434560
Title Neoadjuvant Immunotherapy in Brain Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sarah Sammons, MD
Indications

transitional cell carcinoma

triple-receptor negative breast cancer

ovarian carcinoma

lung squamous cell carcinoma

renal cell carcinoma

melanoma

lung non-squamous non-small cell carcinoma

Advanced Solid Tumor

Therapies

Ipilimumab + Nivolumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST